drugset / Trial / NCT06462027

Packed Red Blood Cell Transfusion During Cardiac Arrest

NCT06462027

Phase 1 Suspended 30 enrolled NYU Langone Health
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this pilot interventional study is to collect preliminary data on administering packed red blood cell (PRBC) during cardiac arrest (CA). The primary objective is to assess the feasibility of PRBC transfusion during cardiac CA to help optimize the methods required to augment cerebral and other vital organ oxygen delivery during cardiopulmonary resuscitation (CPR). The secondary objectives are to assess the effect of PRBC transfusion during prolonged cardiac arrests on cerebral oxygenation, end tidal carbon dioxide (ETCO2), return of spontaneous circulation (ROSC), survival to discharge, biomarkers of neural injury and inflammation, and neurological outcomes at hospital discharge, 30 days post-CA, and 90 days post-CA.

Timeline

Start
2026-06-01
Primary completion
2027-07-01
Completion
2027-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Packed Red Blood Cells Unknown 500 ml Intravenous
Subject Packed Red Blood Cells Unknown 1000 ml Intravenous

Indications